http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0010255-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
filingDate 2000-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1a2c013dc52bc750e88921aa1db763a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_679e5201220e7ec1cacb26877f16d544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9804276f4583a1fd421fb6b7b94093e
publicationDate 2002-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0010255-A
titleOfInvention Pharmaceutical formulation, kit of parts, method for treating a patient suffering from or susceptible to a condition in which inhibition of thrombin and / or inhibition of carboxypeptidase u is required or desired, and, use of a formulation
abstract "PHARMACEUTICAL FORMULATION, KIT OF PARTS, METHOD FOR TREATING A PATIENT SUFFERING FROM OR SUSCEPTIBLE TO A CONDITION IN WHICH THE THROMBIN INHIBITION AND / OR INHIBITION OF CARBOXIPEPTIDASE IS REQUIRED OR DESIRED, AND, USE OF. The present invention relates to a carboxypeptidase U (CPU) inhibitor and a thrombin inhibitor, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, as well as a kit of parts, a method for treating and using the formulations for treating a condition in which inhibition of the CPU and / or inhibition of thrombin is necessary or desired.
priorityDate 1999-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431577138
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90470996
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9EQV9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID113936
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2KIG3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID508222
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56373
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ96IY4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9JHH6

Total number of triples: 37.